Page last updated: 2024-12-05

isomethadone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

isomethadone: RN given refers to parent cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10072
CHEMBL ID2107418
CHEBI ID135321
SCHEMBL ID24513
MeSH IDM0051830

Synonyms (48)

Synonym
isomethadone
3-hexanone, 6-(dimethylamino)-4,4-diphenyl-5-methyl-
dea no. 9226
isometadone [dcit]
isoamidone ii
isometadona [inn-spanish]
1,1-diphenyl-1-(dimethylaminoisopropyl)butanone-2
6-dimethylamino-5-methyl-4,4-diphenyl-3-hexanone
isomethadone ii
isomethadone [inn:ban:dcf]
isomethadonum [inn-latin]
win 1783
nsc-117867
nsc117867
CHEBI:135321
isoamidone
win-1783
ids-ni-001
isomethadone dl-form
isadanone
CHEMBL2107418
unii-12l95qd6kv
466-40-0
isometadone
12l95qd6kv ,
isometadona
isomethadonum
dl-6-(dimethylamino)-4,4-diphenyl-5-methyl-3-hexanone
niosh/mp1931000
MP19310000 ,
dl-isomethadone
3-hexanone, 6-(dimethylamino)-4,4-diphenyl-5-methyl-, (rs)-
SCHEMBL24513
1071551-19-3
isomethadone [inn]
isomethadone dl-form [mi]
3-hexanone, 6-(dimethylamino)-5-methyl-4,4-diphenyl-
levomethadone hydrochloride impurity d [ep impurity]
isomethadone [who-dd]
methadone hydrochloride impurity d [ep impurity]
isomethadone [mi]
IFKPLJWIEQBPGG-UHFFFAOYSA-N
liden (l-form)
isomethadon
CS-7177
HY-U00140
Q6086074
DTXSID40861955
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
diarylmethaneAny compound containing two aryl groups connected by a single C atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (66.67)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.20

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.20 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.20)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]